Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Why SQZ Biotechnologies Sank on Friday

TheMotleyFool

0 0

SQZ Biotechnologies (NYSE: SQZ) fell by nearly 16% on Friday following the company's announcement of a new funding round.

SQZ (pronounced "squeeze") is issuing 3 million new shares of common stock in an underwritten public offering that was priced Friday at $20 per share. This is below the company's $22 per share closing price on Thursday.

As is customary in secondary stock flotations, SQZ's underwriters have been granted a 30-day option to purchase extra stock. In this case, they can buy up to 450,000 shares.

Source Fool.com

Like: 0

SQZ

Teilen